During the past decade, Edward Harkness Eye Institute-Columbia University Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Edward Harkness Eye Institute-Columbia University Medical Center" #1 sponsor was "Glaukos Corporation" with 3 trials, followed by "Stephen Trokel" with 3 trials sponsored, "ThromboGenics" with 2 trials sponsored, "Columbia University" with 1 trials sponsored and "National Eye Institute (NEI)" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Edward Harkness Eye Institute-Columbia University Medical Center" #1 collaborator was "Bascom Palmer Eye Institute" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator and "The New York Eye & Ear Infirmary" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Edward Harkness Eye Institute-Columbia University Medical Center" are "Ectasia" (3 trials), "Keratoconus" (3 trials), "Glaucoma" (2 trials), "ACHROMATOPSIA 7" (1 trials) and "Achromatopsia" (1 trials). Many other conditions were trialed in "Edward Harkness Eye Institute-Columbia University Medical Center" in a lesser frequency.

Most popular intervention types in "Edward Harkness Eye Institute-Columbia University Medical Center" are "Drug" (8 trials), "Device" (6 trials), "Procedure" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "UVA Irradiation" (2 trials), "riboflavin ophthalmic solution" (2 trials), "125 µg Ocriplasmin" (1 trials) and "Ahmed Model FP7 Flexible Plate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Edward Harkness Eye Institute-Columbia University Medical Center" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Edward Harkness Eye Institute-Columbia University Medical Center". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Edward Harkness Eye Institute-Columbia University Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Edward Harkness Eye Institute-Columbia University Medical Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".